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adaptive responses to various stresses.
Li et al. discover that the autophagy-
initiating kinases ULK1/2 also
phosphorylate multiple glycolytic
enzymes to sustain glycolysis and
increase the proportion of glucose flux to
the pentose phosphate pathway during
nutritional stresses.
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Metabolic reprogramming is fundamental to biolog-
ical homeostasis, enabling cells to adjust metabolic
routes after sensing altered availability of fuels and
growth factors. ULK1 and ULK2 represent key inte-
grators that relaymetabolic stress signals to the auto-
phagy machinery. Here, we demonstrate that, during
deprivation of amino acid and growth factors, ULK1/
2 directly phosphorylate key glycolytic enzymes
including hexokinase (HK), phosphofructokinase 1
(PFK1), enolase 1 (ENO1), and the gluconeogenic
enzyme fructose-1,6-bisphosphatase (FBP1). Phos-
phorylation of these enzymes leads to enhanced HK
activity to sustain glucoseuptakebut reduced activity
of FBP1 to block the gluconeogenic route and
reduced activity of PFK1 and ENO1 to moderate
drop of glucose-6-phosphate and to repartition
more carbon flux to pentose phosphate pathway
(PPP), maintaining cellular energy and redox homeo-
stasis at cellular and organismal levels. These re-
sults identify ULK1/2 as a bifurcate-signaling node
that sustains glucose metabolic fluxes besides
initiation of autophagy in response to nutritional
deprivation.
INTRODUCTION
Metazoan cells rely on balanced availability of nutrients including
glucose and amino acids as well as growth factors to maintain
cell growth and survival. By degrading internal cellular compo-
nents, autophagy functions to replenish anabolic substrates
and energy under nutrient-poor or other stress conditions as
well as in diverse pathophysiological processes (Choi et al.,2013; Rabinowitz and White, 2010; Wang et al., 2010; Xie and
Klionsky, 2007). Genetic delineation of the critical components
for autophagy has revealed numerous factors (Galluzzi et al.,
2014; Mizushima et al., 2011; Nakatogawa et al., 2009), among
which unc-51-like kinase 1 and 2 (ULK1/2) play an initiating
role by coupling signals from nutrient-sensing proteins, including
mechanistic target of rapamycin (mTOR) and AMP-activated
protein kinase (AMPK) to the downstream autophagic factors,
leading to the formation of autophagosomes (Egan et al., 2011;
Kim et al., 2011; Jung et al., 2009). However, whether ULK1/2
may act as a multi-branching node connecting nutritional stress
signals to other metabolic pathways, such as the pathways for
glucose metabolism, remains unknown.
Glucose is the most-common source of energy for almost all
living organisms, and exquisite mechanisms in the regulation
of glucose metabolic fluxes have been evolved to enable cells
to meet different intrinsic growth requirements or to adapt to var-
iations of extracellular nutritional supply (Hammerman et al.,
2004; Levine and Puzio-Kuter, 2010; Wellen and Thompson,
2012). In mammalian cells, glucose catabolism starts with its
conversion to glucose-6-phosphate (G6P), which is catalyzed
by hexokinase (HK), a rate-limiting step of glycolysis (Wilson,
2003). G6P is the branch point for proceeding to glycolysis or
the pentose phosphate pathway (PPP) or to be stored as
glycogen in certain type of cells. For glycolysis, G6P is first iso-
merized to fructose-6-phosphate (F6P) that is further converted
into fructose-1,6-bisphosphate (F-1,6-P) by phosphofructoki-
nase 1 (PFK1), the committed step of glycolysis (Mor et al.,
2011). Following the split of F-1,6-P into two trioses by aldolases,
enolase 1 (ENO1) functions in the conversion of 2-phosphoglyc-
erate (2PG) to phosphoenolpyruvate (PEP), the ninth and penul-
timate step of glycolysis (Dı́az-Ramos et al., 2012). FBP1 re-
verses the reaction catalyzed by PFK1 and plays a vital role in
gluconeogenesis. Recent studies also revealed that inhibition
of FBP1 enzymatic activity strongly increases glycolysis both in
non-transformed and tumor cells (Dong et al., 2013; Li et al.,
2014).Molecular Cell 62, 359–370, May 5, 2016 ª2016 Elsevier Inc. 359
The PPP shunt is considered as the major contributor of
reducing equivalents in the form of reduced nicotinamide
adenine dinucleotide phosphate (NADPH) for reductive biosyn-
thesis and maintaining cellular redox homeostasis (Fan et al.,
2014). Inborn errors in PPP have been observed to be associated
with various diseases such as fava-bean-induced hemolytic
anemia, known as favism, which is caused by the deficiency of
G6P dehydrogenase (G6PD), an X-linked recessive genetic con-
dition that is particularly common in people of Mediterranean
and African origin (Beutler, 2008). G6PD is the rate-limiting
enzyme that catalyzes the initial step of the PPP shunt, oxidizing
G6P to phosphogluconolactone while nicotinamide adenine
dinucleotide phosphate (NADP+) is reduced to NADPH. Regula-
tion of glycolytic enzymes to increase the PPP flux has been
demonstrated as an important way for cells to adapt to various
stresses (Bensaad et al., 2006; Yi et al., 2012; Anastasiou
et al., 2011).
Here, by combining in vitro reconstitution assays, generation of
phospho-specific antibodies, andgeneticmanipulation,we iden-
tify HK, PFK1, FBP1, and ENO1 in the glucose metabolic path-
ways as direct phosphorylation substrates of ULK1/2. Phosphor-
ylation of these enzymes occurs virtually only under nutritional
stresses.Metabolomic analyses illustrate that, besides their clas-
sical role in the induction of autophagy to recycle cellular compo-
nents to sustain energy supply and limit the generation of reactive
oxygen species (ROS) during nutritional stresses, ULK1/2 func-
tion in themaintenance of intracellular energy and redox balance
by allocating more G6P to the PPP to promote the generation of
reducing potential for ROS detoxification while sustaining overall
glucose catabolism. These findings establish an important adap-
tive mechanism for the reprogramming of glucose metabolic
fluxes in response to nutrient deprivation, and understanding of
this regulatory mechanism may offer us new strategies for pre-
vention and treatment of human metabolic diseases.
RESULTS
Depletion of ULK1/2 Leads to Reduction of Glycolytic
Flux during Amino Acid and Serum Starvation
To explore a possible link between ULK1/2 activation and regu-
lation of glucose metabolism, we first knocked down ULK1 and
ULK2 separately or together in the human colorectal cancer
HCT116 cells (Figure 1A). Despite the presence of glucose,
ULK1/2 can be activated upon deprivation of amino acid and/
or serum (Lin et al., 2012; Russell et al., 2013; Shang et al.,
2011). We found that, whereas knockdown of either ULK1 or
ULK2 singly led to a moderate reduction in the rates of glucose
consumption and lactate production in starvation medium
lacking both amino acid and serum, ULK1 and ULK2 double
knockdown (ULK1/2 DKD) resulted in a severe reduction of
glycolytic flux (Figure 1A), indicating that both ULK1 and ULK2
are involved in themaintenance of glucose catabolism. Similarly,
depletion of ULK1/2 in human osteosarcoma U2OS cells, human
breast cancer MCF7 cells, or mouse embryonic fibroblasts
(MEFs) also resulted in significant reduction of glucose utilization
during the starvation (Figures 1B and S1A–S1E), demonstrating
that ULK1/2 play a general role in regulating glucose metabolism
in various cell types. Likewise, wild-type (WT) cells also dis-360 Molecular Cell 62, 359–370, May 5, 2016played higher glucose consumption and lactate production
than cells depleted of ULK1/2 after treatment of rapamycin
that activates ULK1 by inhibiting mTORC1-mediated phosphor-
ylation at Ser758 (Figure S1F). Moreover, reconstitution of the
ULK1/2 DKD cells with WT-ULK1, but not with its catalytically
inactive (KI) form, restored the glycolytic flux during starvation
(Figures 1C and S1G).
The kinase activities of ULK1/2 are highly dependent on their
assembling into an 3-MDa complex with at least FIP200,
ATG13, and ATG101 subunits, and depletion of any of these
components would render ULK1/2 inactive (Hara et al., 2008;
Hosokawa et al., 2009a, 2009b). We therefore knocked down
these genes in HCT116 cells separately (Figures S1H–S1J) and
observed similar reduction of glycolytic flux to that caused by
depletion of ULK1/2 (Figures 1D and S1L). To assess whether
the attenuation of glucose catabolism was directly caused by
the decrease of autophagic activity resulting from the disruption
of ULK1/2 complex, several downstream genes essential for
autophagy (Galluzzi et al., 2014; Mizushima et al., 2011; Rabino-
witz and White, 2010; Xie and Klionsky, 2007), including ATG5,
ATG7, andBECN1, were separately knocked down (Figure S1K).
Interestingly, no significant changes of glucose consumption
and lactate production were detected in the knockdown cells
compared to the control cells (Figures 1D and S1L). Similar re-
sults were also obtained using Atg5/ MEFs (Figures 1E and
S1M), in which conventional autophagy is fully blocked (Kuma
et al., 2004). Together, these results indicate an important role
of ULK1/2 in the regulation of glycolytic flux independent of the
downstream autophagic events.
We next assayed the activities of enzymes in the glycolytic
pathway by using lysates from control and ULK1/2 DKD
HCT116 cells placed either in complete medium or medium
deprived of both amino acid and serum. Intriguingly, it was found
that starvation led to increased catalytic activity of HK but
reduced activity of PFK1. Reduced activities caused by starva-
tion were also detected for FBP1 and ENO1. Meanwhile, the
changes of the activities of the four enzymes after starvation
did not occur in ULK1/2 DKD cells (Figures 1F–1I). We also per-
formed similar experiments inWT andUlk1/2/MEFs and found
again that, in the absence of Ulk1/2, these metabolic enzymes
were much less sensitive to starvation (except that the activity
of FBP1 in MEFs was too low to be detected; Figures S1N–
S1Q). Of note, the activities of many other metabolic enzymes,
such as phosphoglycerate kinase (PGK) or G6PD, did not show
significant variation in either control orULK1/2DKD cells (Figures
S1S and S1T). Importantly, total protein levels for all the meta-
bolic enzymes tested were unchanged (Figures 1J, S1R, and
S1U). In addition, the enzymatic activities of HK, PFK1, and
ENO1 changed similarly during starvation in Atg5/ MEFs to
those in the WT MEFs (Figures S1V–S1Z), confirming that auto-
phagic activity per se is not required for the regulation of glyco-
lytic flux during amino acid and serum starvation.
ULK1 Directly Phosphorylates Glycolytic Enzymes and
Affects Their Enzymatic Activities
We next asked whether HK, PFK1, FBP1, and ENO1 could be the
direct substrates for the serine/threonine kinases ULK1/2. Co-























































































































































































































































































-AA/Serum 0 2 0 2 -AA/Serum 0 2 0 2 -AA/Serum 0 2 0 2 -AA/Serum 0 2 0 2
Figure 1. ULK1/2 Deficiency Leads to Reduction of Glycolytic Flux during Amino Acid and Serum Starvation
(A) Lentivirus-mediated knockdown ofULK1 and/orULK2 (left). ACTINwas used as a loading control. Glucose consumption (center) and lactate production (right)
of HCT116 cells expressing control shRNA (ctrl) or shRNAs targeting ULK1 and/or ULK2 in complete medium or medium free of amino acid and serum (n = 4
experiments) are shown.
(B) Glucose consumption of WT or Ulk1/2/ MEFs placed in complete medium or medium free of amino acid and serum (n = 4 experiments).
(C) Reconstitution of WT-ULK1 or KI-ULK1 in ULK1/2 double knockdown (ULK1/2 DKD) cells (left). Glucose consumption (right) of ULK1/2 DKD cells recon-
stituted with WT-ULK1, KI-ULK1, or empty vector in complete medium or medium free of amino acid and serum (n = 4 experiments) is shown.
(D) Glucose consumption of HCT116 cells with shRNA targeting FIP200, ATG13, ATG101, ATG5, ATG7, or BECN1 in medium free of amino acid and serum (n = 4
experiments).
(E) Glucose consumption of WT or Atg5/ MEFs placed in complete medium or medium free of amino acid and serum (n = 4 experiments).
(F–I) Enzyme activities of HK (F), PFK1 (G), FBP1 (H), and ENO1 (I) in control (ctrl) or ULK1/2 DKD HCT116 cells placed in complete medium or medium free of
amino acid and serum for 2 hr (n = 5 assays).
(J) Immunoblotting for the protein levels of the enzymes described in (F)–(I).
Error bars denote SEM. Statistical analysis was performed by ANOVA followed by Tukey in (A), (C), (D), and (F)–(I) and by Student’s t test in (B) and (E) (*p < 0.05;
**p < 0.01; N.S., not significant). See also Figure S1.forms of these four metabolic enzymes resulted in different elec-
trophoreticmobility shifts in gels containing Phos-tag that retards
the mobility of phosphorylated proteins (Figure 2A; Kinoshita
et al., 2006). Treatment of the immunoprecipitated enzymes
with calf-intestinal alkaline phosphatase (CIP) effectively dimin-
ished theupper bands (Figure 2A). In vitro kinase assaysusingpu-
rified bacterially expressed metabolic enzymes and purified His-
tagged ULK1 expressed in insect cells further confirmed that
ULK1 could directly phosphorylate these enzymes (Figure 2B).
Similar results were also obtained using ULK2 as the kinase
(data not shown).The four phosphorylated enzymes were then subjected to
mass spectrometry, and multiple phosphorylated serine resi-
dues for each enzyme were identified (Figures S2A–S2D). Mu-
tants carrying alterations of these serine residues to alanine
singly or in combination were then constructed. It was found
that, for HK1, combined mutation of Ser124 and Ser364 to alanine
strongly diminished the phosphorylation signal (Figure 2C); for
PFK1 (M isoform), Ser74 and Ser762 were identified to be the crit-
ical residues (Figure 2D); for FBP1, simultaneous mutation of
Ser63 and Ser88 abolished its phosphorylation (Figure 2E); and
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Figure 2. Direct Phosphorylation of Glycolytic Enzymes by ULK1 In Vivo and In Vitro
(A) Changes of the electrophoretic mobility of Flag-tagged HK1, PFK1 (M isoform), FBP1, and ENO1 co-expressed with HA-tagged WT-ULK1 or KI-ULK1 in
HEK293T cells on Phos-tag-containing gels (Phos.). CIP, calf-intestinal alkaline phosphatase; TCL, total cell lysates. (Right) Schematic diagram shows the
enzymes of glucose metabolic fluxes phosphorylated by ULK1 (circled in red).
(B) In vitro phosphorylation of HK1, PFK1, FBP1, and ENO1 by ULK1.
(C–F) Electrophoretic mobilities of Flag-tagged WT or SA mutants of HK1 (C), PFK1 (D), FBP1 (E), and ENO1 (F) co-expressed with HA-ULK1 in HEK293T cells.
(G) Phosphorylation of metabolic enzymes in control or ULK1/2 DKD HCT116 cells placed in complete medium or medium free of amino acid and/or serum for
2 hr.
(H) Phosphorylation of metabolic enzymes in ULK1/2 DKD HCT116 cells reconstituted with Flag-tagged WT-ULK1, KI-ULK1, or empty vector placed in medium
free of amino acid and serum for 2 hr.
(I) Phosphorylation of metabolic enzymes in HCT116 cells in complete medium with or without 50 nM rapamycin or in medium free of amino acid and serum for
2 hr.
See also Figure S2.(Figure 2F). Sequence alignment indicates that most of these
serine residues targeted by ULK1 are highly conserved across
different species (Figures S2A–S2D). Importantly, the amino
acid sequences flanking the phosphorylated residues generally
conform to the consensus phosphorylation motif identified pre-
viously for the substrates of ULK1 (Egan et al., 2015) or ATG1
(yeast ortholog of ULK1/2; Papinski et al., 2014). Polyclonal an-
tibodies that specifically recognize Ser762-phosphorylated
PFK1, Ser63-phosphorylated FBP1, or Ser282-phosphorylated
ENO1 was then produced (Figures 2D–2F). Ser124-phosphory-
lated HK1 happens to be recognized by a commercially available
antibody that targets a sequence context-dependent phospho-
serine motif (referred here as P-S124-HK1 antibody; Figure 2C).
We found that the amount of either the exogenous or endoge-
nous phosphorylated enzymes increases in medium deprived362 Molecular Cell 62, 359–370, May 5, 2016of amino acid and/or serum, whereas knockdown of ULK1/2
abolished their phosphorylation (Figures 2G and S2E). Further-
more, reconstitution of ULK1/2 DKD cells with WT-ULK1, but
not KI-ULK1, restored the phosphorylation of these enzymes
(Figure 2H). Finally, treatment of rapamycin, which is known to
active ULK1/2 as a result of inhibition of mTOR, in HCT116 cells
also induced the phosphorylation of these enzymes (Figure 2I).
These in vitro and in vivo results indicate that ULK1 is a bona
fide kinase for HK, PFK1, FBP1, and ENO1.
We next tested whether phosphorylation of these enzymes by
ULK1 directly accounts for the changes of their enzymatic activ-
ities. Co-expression of ULK1 strongly increased the activity of
WT-HK1, whereas the activities of WT forms of PFK1, FBP1,
and ENO1 were heavily suppressed by ULK1 (Figures 3A–3E).
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Figure 3. Phosphorylation Modulates the
Enzymatic Activities of HK, PFK1, FBP1,
and ENO1
(A) Immunoblotting of Flag-tagged enzymes and
their mutants co-expressed with HA-tagged ULK1
in HEK293T cells using regular SDS-PAGE gels
(ctrl) or Phos-tag-containing gels (Phos.).
(B–E) Enzymatic activities of WT, SA, or SD form of
HK (B), PFK1 (M isoform; C), FBP1 (D), and ENO1
(E) assayed with abundant supply of their respec-
tive substrates (n = 5 assays).
Error bars denote SEM. Statistical analysis was
performed by ANOVA followed by Tukey (**p <
0.01). See also Figure S3.(SA mutants or 2SA-) of these enzymes were not affected. The
serine to aspartate mutants for each enzyme were also created
(SD mutants or 2SD-), and it was found that 2SD-HK1 and
2SD-FBP1 can well mimic the phosphorylated states of these
two enzymes whereas 2SD-PFK1 and 2SD-ENO1 own prosper-
ities more like their respective SA mutants (Figures 3A–3E). We
also determined the Michaelis constant (Km) values of the en-
zymes and found that ULK1-mediated phosphorylation had little
effect on the binding affinity of each enzyme to its substrate (Fig-
ure S3A). The spatial locations of the serine residues targeted by
ULK1 are shown in Figure S3B by structural remodeling.
Phosphorylation of HK and FBP1 by ULK1 Sustains
Glycolytic Rate whereas ULK1-Mediated
Phosphorylation of PFK1 and ENO1 Promotes PPP Flux
To explore the functional consequences of ULK1-mediated
phosphorylation of these enzymes of glucosemetabolism during
nutritional stresses, we first generated HCT116 cell lines in which
the expression of HK (including HK1 and HK2), PFK1 (including
M, L, and P isoforms), FBP1, or ENO1 was stably knocked
down (Figure S4A). As expected, depletion of HK, PFK1, or
ENO1 exhibited decreased glucose consumption and lactate
production, whereas cells expressing short hairpin RNA
(shRNA)-targeting FBP1 that functions in the gluconeogenic
route showed increased glycolytic flux (Figures 4A and S4B;
Dong et al., 2013; Li et al., 2014). We then reintroduced WT,
SA, or SD forms of HK1, PFK1 (M isoform), FBP1, and ENO1,
respectively, into those knockdown cells (Figures 4B–4E). It
was found that cells reconstituted with SA mutant of HK1 or
FBP1 showed lower levels of glucose uptake and utilization
compared to those of the HK-KD or FBP1-KD cells expressing
WT form of HK1 or FBP1 during amino acid and serum starvation
(Figures 4F, S4C, and S4D). Meanwhile, cells reconstituted with
the phosphor-mimetic SDmutant of HK1 or FBP1 demonstrated
constitutively higher capacity in the uptake and utilization of
glucose (Figures 4F, S4C, and S4D). In contrast, cells expressing
SA or SDmutant of PFK1 or ENO1 exhibited increased glycolytic
flux than that of cells expressing their correspondingWT forms in
response to starvation (Figures 4G and S4E).
Importantly, the increasedHKenzymatic activityanddecreased
activities of PFK1 and ENO1 during ULK1/2 activation may in-crease the ratio of glucose flux going through PPP to keep gener-
ating reducing forces to eliminate the elevated ROS during amino
acid and serum deprivation (Scherz-Shouval et al., 2007). Using
[1,2-13C]glucose as a tracer, glycolytic intermediates including
G6P/F6P, FBP,GAP/DHAP, 2PG/3PG,PEP,pyruvateand lactate,
and PPP intermediates including R5P/X5P, E4P, and S7P were
measured by liquid chromatography-tandem mass spectrometry
(LC-MS/MS) (Figure S4F).We found thatHK-KD or FBP1-KD cells
reconstituted with SA form of HK1 or FBP1 contained lower levels
of labeled glycolytic and PPP intermediates than cells reconsti-
tutedwith their correspondingWT formscultured in starvationme-
dium, but not in completemedium (Figures 4H, 4I, S4G, and S4H).
On the other hand, cells reconstituted with 2SA-PFK1 or 2SA-
ENO1 contained lower levels of their corresponding upstream
glycolytic intermediates (G6P/F6P for PFK1 and G6P/F6P, FBP,
and GAP/DHAP for ENO1) and all the PPP intermediates but
higher levels of their corresponding downstream intermediates
(FBP, GAP/DHAP, 2PG/3PG, PEP, pyruvate, and lactate for
PFK1 and 2PG/3PG, PEP, pyruvate, and lactate for ENO1) than
cells reconstituted with their WT counterparts during starvation
(Figures 4J, 4K, S4I, and S4J). Meanwhile, we found that
30.6% ± 4.5% of HK1, 38.8% ± 5.2% of PFK1, 25.5% ± 4.0% of
FBP1, and 32.1% ± 6.7% of ENO1 are phosphorylated by
ULK1/2 after amino acid and growth factor starvation (Figure 4L).
Furthermore, ULK1/2 DKD cells displayed severely decreased
intracellular G6P, PEP, pyruvate, and lactate levels during the
starvation compared to those in control cells (Figures S4M
and S4N).
With the isotope labeling as designed, lactate containing one
13C atom (*) (M+1) is derived only from PPP flux (Figure S4F)
whereas lactate containing two 13C atoms (**) (M+2) is mostly
derived from direct glycolytic flux without going through PPP.
We found that, during amino acid and serum starvation, PFK1-
KD cells reconstituted with WT-PFK1 displayed higher PPP
flux (based on the ratio of lactate* versus lactate**) comparing
to PFK1-KD cells expressing 2SA-PFK1 (Figure 4M). Similar re-
sults were obtained in ENO1-KD cells reconstituted with WT-
ENO1 and 2SA-ENO1. The differences of PPP flux were not
found in those cells cultured in complete medium (Figure S4K).
In addition, HK-KD or FBP1-KD cells expressing SA mutant of
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Figure 4. Phosphorylation of Glucose Metabolic Enzymes by ULK1 Sustains Glycolytic Rate and PPP Flux
(A) Glucose consumption of HCT116 cells expressing control shRNA (ctrl) or shRNAs targeting HK, PFK1 (M, L, and P isoform), FBP1, or ENO1 (n = 3 assays).
(B–E) HCT116 cells expressing control shRNA or shRNAs targetingHK (B),PFK1 (M, L, and P isoform; C), FBP1 (D), or ENO1 (E) reconstitutedwith empty vector or
WT, SA, or SD form of HK1, PFK1 (M isoform), FBP1, or ENO1.
(F and G) Glucose consumption of cells with knockdown of glucose metabolic enzymes reconstituted with their respective WT, SA, or SD mutant placed in
complete medium or medium free of amino acid and serum (n = 4 assays).
(H–K) LC-MS/MS results of labeled intracellular glycolytic and PPPmetabolites derived from [1,2-13C]glucose in HCT116 cells with knockdown ofHK (H), FBP1 (I),
PFK1 (J), or ENO1 (K) reconstituted with their respectiveWT or SAmutant placed in medium free of amino acid and serum (n = 3 experiments). See Supplemental
Information for full names of metabolites.
(L) Electrophoretic mobilities of Flag-tagged enzymes in cells as described in (B)–(E) placed in complete medium or medium free of amino acid and serum for 2 hr
on Phos-tag-containing gels (Phos.).
(M) LC-MS/MS-based measurement of PPP flux (calculated as the ratio of peak areas of lactate labeled with one 13C carbon [PPP flux] over that labeled with two
13C carbons [direct glycolytic flux without going through PPP] and the first value analyzed is normalized to 1) of HCT116 cells with knockdown of glycolytic
enzymes reconstituted with their corresponding WT or SA mutant in medium free of amino acid and serum (n = 3 experiments).
(N) The PPP flux of WT or Ulk1/2/ MEFs placed in complete medium or medium free of amino acid and serum (n = 3 experiments).
Error bars denote SEM. Statistical analysis was performed by ANOVA followed by Tukey in (A), (F), and (G) and by Student’s t test in (H)–(N) (*p < 0.05; **p < 0.01).
See also Figure S4.their corresponding WT forms at all times (Figures 4M and S4K).
The PPP results were confirmed by measuring the PPP-depen-
dent 14CO2 production from [1-
14C]glucose (Figure S4L) and by364 Molecular Cell 62, 359–370, May 5, 2016NMR spectroscopy-based method (Figures S4O and S4P).
Importantly, we detected a robust increase in the ratio of PPP
flux versus direct glycolytic flux during amino acid and serum
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Figure 5. ULK1-Mediated Phosphorylation of Glycolytic Enzymes Protects Cells from ROS-Associated Cell Death
(A–C) Levels of NADPH/NADP+ (A), GSH (B), and cell death rate (C) of cells with knockdown of different enzymes and reconstituted with their corresponding WT,
SA, or SD mutant placed in medium free of amino acid and serum (2 hr for A and B; 18 hr for C; n = 3 experiments).
(D) Lentivirus-mediated knockdown of G6PD in HCT116 cells.
(E) ROS level of cells expressing control shRNA or shRNA-targeting G6PD placed in medium free of amino acid and serum for 2 hr (n = 3 experiments).
(F) Cell death rate of HCT116 cells as described in (D) placed in medium free of amino acid and serum for the indicated periods of time (n = 3 experiments).
(G andH) ROS level and cell death rate of control cells orULK1/2DKD cells placed inmedium free of amino acid and serumwith or without 2mMN-acetylcysteine
(NAC) (n = 3 experiments).
Error bars denote SEM. Statistical analysis was performed by ANOVA followed by Tukey (*p < 0.05; **p < 0.01). See also Figure S5.starvation in WT, but not in Ulk1/2/, MEFs (Figures 4N and
S4Q). Similarly, knocking down of ULK1/2 also decreased the
PPP flux in U2OS andMCF7 cells during starvation (Figure S4R).
ULK1-Mediated Phosphorylation of Glucose Metabolic
Enzymes Protect Cells from ROS-Associated Cell Death
Consistent with the crucial function of PPP in generation of
reducing power, intracellular NADPH/NADP+ and GSH levels
decreased in PFK1-KD or ENO1-KD cells expressing SA or SD
mutant of PFK1 or ENO1 during starvation comparing to their
corresponding WT controls (Figures 5A and 5B). Moreover,
much-higher ROS levels and higher percentages of cell death
were detected in starved cells with knockdown of enzymes re-
constituted with SA mutants of HK1, FBP1, PFK1, or ENO1
than cells expressing their WT counterparts (Figures S5A and
5C). In addition, cells expressing SD mutant of HK1 or FBP1
demonstrate lower ROS and the percentage of cell death than
cells expressing the WT form whereas 2SD-PFK1 or 2SD-
ENO1 owns prosperities more like their respective SA mutants
(Figures S5A and 5C).
Next, we blocked the entry of G6P to PPP by knocking down
G6PD, the rate-limiting enzyme for PPP (Figure 5D), and found
that depletion of G6PD strongly increased the ROS level and
accelerated cell death in starved HCT116 cells (Figures 5E and
5F). Finally, addition of antioxidant N-acetylcysteine (NAC) or
catalase (CAT) that catalyzes the conversion of hydrogen
peroxide to water and oxygen effectively decreased the ROSlevel and alleviated cell death in ULK1/2 DKD or Ulk1/2/ cells
in response to starvation (Figures 5G, 5H, and S5B).
The higher level of 3PG in cells expressing WT-ENO1
comparing to those expressing 2SA-ENO1 during starvation
(Figure 4K) could possibly lead to more-active de novo serine
synthesis to further support the production of NADPH (Fig-
ure S5C). However, in the absence of amino acids, serine
pathway, which requires input from glutamine for transamination
reaction, is most likely blocked. Indeed, we found that depletion
of PHGDH, the first enzyme directing 3PG to the serine pathway,
did not affect ROS, NADPH/NADP+, or cell death level in HCT116
cells during amino acid and serum starvation (Figures S5D–S5H),
indicating that serine pathway did not significantly contribute to
the production of NADPH under such circumstance.
ULK1/2 Reprogram Glucose Metabolism Independently
of Autophagy
To further ascertain an autophagy-independent role of ULK1/2 in
the regulation of glucose metabolism, we analyzed the glucose
metabolic fluxes in Atg5/ MEFs with or without knockdown
of Ulk1/2. As previously reported (Kuma et al., 2004), autophagy
was deficient in Atg5/ MEFs as monitored with the degrada-
tion of p62 and lipidation of microtubule-associated protein 1
light chain 3 (LC3) during amino acid and serum starvation (Fig-
ure 6A). We found that, in cells expressing shRNAs targeting
Ulk1/2 in the Atg5/ background, significantly lower glucose









0 6 12 0 6 12 0 6 12






WT MEFs Atg5-/- MEFs 












   









































































































   
   
50
   




WT MEFs Atg5-/- MEFs F
Annexin V staining
WT MEFs + ctrl shRNA 
Atg5-/- MEFs + ctrl shRNA 

























   
   
50
   




   
   
50
   




   
   
50
   




   
   
50
   




   
   
50
   




   
   
50
   




   
   
50
   




   
   
50
   


















































0      102   105 0      102   105 0      102   105 
MEFs  WT    Atg5-/- MEFs  WT    Atg5-/-
**














Figure 6. ULK1/2 Reprogram Glucose Metabolism Independently of Autophagy
(A) Lentivirus-mediated knockdown of Ulk1/2 in Atg5/ MEFs. Cells were placed in medium free of amino acid and serum for the indicated periods of time.
(B) Glucose consumption (left), lactate production (center), and ratio of PPP flux versus the direct glycolytic flux (right) of WT or Atg5/ MEFs expressing control
shRNA (ctrl) or shRNAs targeting Ulk1/2 cultured in complete medium or medium free of amino acid and serum (n = 4 experiments).
(C–E) Levels of NADPH/NADP+ (C), GSH (D), and ROS (E) in WT or Atg5/ MEFs expressing control shRNA (ctrl) or shRNAs targeting Ulk1/2 placed in medium
free of amino acid and serum for 2 hr (n = 3 experiments).
(F) Cell death rate of WT or Atg5/ MEFs expressing control shRNA or shRNAs targeting Ulk1/2 placed in complete medium or medium free of amino acid and
serum with or without CAT (600 U/ml) for 18 hr. Statistical results of three independent experiments are shown on the right.
Error bars denote SEM. Statistical analysis was performed by ANOVA followed by Tukey (*p < 0.05; **p < 0.01).observed under starvation condition (Figure 6B). Moreover,
knockdown of Ulk1/2 in Atg5/ MEFs led to a further decrease
of NADPH/NADP+ as well as GSH and a further increase of
ROS level and percentage of cell death compared to those in
Atg5/ MEFs (Figures 6C–6F), and addition of CAT, the antiox-
idant, strongly alleviated cell death in response to starvation (Fig-
ure 6F). These results suggest that, during nutritional stresses,
autophagy contributes to the maintenance of cellular redox ho-
meostasis whereas ULK1/2 function simultaneously to further
accelerate ROS clearance and enhance cell survival by direct re-
programming of glucose metabolism.
ULK1/2 Maintain Glycolytic Flux, PPP, and Redox
Homeostasis at Both Cellular and Organismal Levels
Lacking mitochondria, red blood cells (RBCs) extensively rely on
glycolysis for energy production and PPP to generate reducing
forces to eliminate ROS from both endogenous and exogenous
sources (Beutler, 2008). The ROS would otherwise damage
RBCs and impair their ability in oxygen delivery, which contrib-
utes to the pathology of a number of diseases (Mohanty et al.,
2014; Patra and Hay, 2014). We found that, like FIP200/
mouse embryos (Gan et al., 2006), most of Ulk1/2/ embryos366 Molecular Cell 62, 359–370, May 5, 2016are especially pale at embryonic day 15.5 (E15.5) compared to
their WT littermates (Figure S6A). Interestingly, deficiency of
Ulk1 alone, but not Ulk2, led to increased accumulation of p62
and themitochondrial marker protein CoxIV (Figure 7A), confirm-
ing an important autophagic role of Ulk1 in erythrocyte matura-
tion (Kundu et al., 2008). However, much-reduced glycolytic
flux and PPP activity as well as increased ROS level were de-
tected in RBCs from Ulk1/2/, but not from Ulk1/ or Ulk2/
embryos (Figures 7B, 7C, S6B, and S6C), indicating a comple-
mentary but pivotal function of Ulk1 and Ulk2 in the regulation
of glucose metabolism of RBCs during embryonic period in vivo.
In line with these findings, we found that Ulk1/2/ RBCs are
more prone to lysis (Figure S6D) and displayed fractured mem-
brane (Figure S6E). More intriguingly, unlike MEFs and other
cells, Ulk1/2/ RBCs display altered glucose utilization even
in complete medium (Figure 7B). The critical role of Ulk1 during
maturing of RBCs suggests its activation in spite of abundant
supply of nutrients around (Kundu et al., 2008). Indeed, we found
that, even under complete medium condition, mTORC1 activity
in RBCs is maintained in an inactive state (Figure 7D), likely
because RBCs lack lysosome, which is essential for mTORC1
activation (Laplante and Sabatini, 2012), allowing Ulk1/2 to be
- + - - + -
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Figure 7. ULK1/2 Maintain Glycolytic Flux,
PPP, and Redox Homeostasis at Both
Cellular and Organismal Levels
(A) Red blood cells (RBCs) from embryos of
different genotypes were extracted and subjected
to immunoblotting.
(B) Glucose consumption (left) and ratio of PPP flux
versus the direct glycolytic flux (right) of RBCs from
embryos of different genotypes placed in com-
plete medium or medium free of amino acid and
serum (n = 4 experiments).
(C) Representative ROS level of RBCs from em-
bryos of different genotypes.
(D) Cell lysates of WT MEFs or WT RBCs placed in
complete medium or medium free of amino acid
and serum for 2 hr or treated with 50 nM rapamycin
for 2 hr in complete medium were immunoblotted
as indicated.
(E) Weights of the embryos of Ulk1+/+Ulk2/,
Ulk1+/Ulk2/, and Ulk1/2/ at embryonic day
15.5 (E15.5) from Ulk1+/Ulk2/ mouse parents.
During the breeding, half of the mice had access to
normal water and the other half to water supple-
mented with 40 mM NAC. Only litters containing
Ulk1/2/ embryos were included in the analysis.
(F) Model for ULK1/2-mediated regulation of
glucose metabolic fluxes.
Error bars denote SEM. Statistical analysis was
performed by ANOVA followed by Tukey in (B) and
(E) (*p < 0.05; **p < 0.01). See also Figure S6.constantly activated. Next, we used NAC, the ROS scavenger, to
test whether administration of this antioxidant could rescue the
defects of Ulk1/2/ embryos. In consonance with the results
obtained in HCT116 and MEFs showing that addition of NAC
or the other antioxidant, CAT, effectively decreased the ROS
level and mitigated cell death in ULK1/2 DKD or Ulk1/2/ cells
during nutrient starvation (Figures 5G, 5H, and S5B), we found
that supply of NAC alleviated the paleness of Ulk1/2/ embryos
(Figure S6F). Moreover, we found that the body weight of Ulk1/
2/ mouse embryos (Cheong et al., 2014) was also restored
to normal range in response to the supply of NAC (Figure 7E).
These results demonstrate that the failure in the maintenance
of a regular PPP flux, which further leads to the disrupted redox
balance, is the major cause for the many defects of Ulk1/2/
embryos.MoDISCUSSION
In this study, we demonstrate a model
that, under deprivation of amino acid
and growth factors, the autophagy-initia-
tion kinases ULK1/2 act as a key signaling
node to sustain glycolysis and at the
same time repartition more carbon flux
to PPP through phosphorylating multiple
enzymes in the glucose metabolic path-
ways, including HK, PFK1, FBP1, and
ENO1 (Figure 7F). On one hand, phos-
phorylation of HK renders its enzymatic
activity increased, promoting the con-version of glucose to G6P and subsequently glucose uptake,
such that the glycolytic flux is sustained in control cells
compared to cells depleted of ULK1/2 under the same nutritional
stresses. It is also important to note that, because HK is pro-
duct inhibited by G6P, the increase in the Vmax of HK by ULK1/
2-mediated phosphorylation could probably compensate for
the higher product inhibition of G6P in ULK1/2-containing cells
during starvation. Meanwhile, the reduced activity of FBP1 after
ULK1/2-dependent phosphorylation minimizes the reversal of
F-1,6-P back to F6P, indirectly drawing more glucose toward
catabolism.
On the other hand, ULK1/2-mediated phosphorylation of
PFK1 and ENO1 inhibits their enzymatic activity and modulates
glycolytic flux in an opposite way comparing to the effects of
HK and FBP1 when assayed individually (Figures 4F, 4G, S4C,lecular Cell 62, 359–370, May 5, 2016 367
and S4E). A critical issuewould be how the inhibition of PFK1 and
ENO1 activity by ULK1/2 can be reconciled to the sustained
glycolysis observed in WT cells (Figures 1A, 1B, and S1C–
S1E). One possibility is that the contribution of phosphorylated
HK1 and FBP1 in stimulating overall glycolysis may override
the opposite effects caused by inhibition of PFK1 and ENO1 as
the varied enzymatic activities after phosphorylation by ULK1/2
sum up to sustain glycolysis under nutritional stress. It is also
formally possible that ULK1/2 can phosphorylate more as-yet-
unidentified substrates involved in glucose metabolism, which
would await advent of a complete plethora of the targets of
ULK1/2. Nevertheless, it is clear that inhibition of the enzymatic
activities of PFK1 and ENO1 acts to maintain the level of G6P
based on our metabolomic studies and thereby likely to divert
relatively more glucose flux to PPP (Figures 4J–4M, S4L, and
S4P). Previous work showed that inhibition of PFK1 byO-GlcNA-
cylation during hypoxia promotes PPP activity and enhances cell
survival (Yi et al., 2012), emphasizing the importance of repres-
sion of PFK1 in maintaining PPP activity during stresses. Another
concern is that the blunted ENO1 activity after ULK1/2-mediated
phosphorylation may have an adverse effect on the processing
of intermediates recovered from the non-oxidative branch of
PPP. In fact, the intermediates from PPP in the form of GAP
and F6P can also be converted back to G6P and replenish the
oxidative branch of PPP (Riganti et al., 2012), forming a closed
cycle of PPP that excludes ENO1 activity under circumstances
such as nutrient deprivation when large amount of NADPH is
needed, such that a relatively higher PPP flux can be continu-
ously maintained (Figures 4M, S4L, and S4P). In support of the
above notion is that suppression of pyruvate kinase M2, which
is located downstream of ENO1 in the glycolytic pathway, diverts
more glucose to PPP in response to oxidative stress (Anastasiou
et al., 2011).
It is commonly believed that gluconeogenesis occursmostly in
hepatic and renal cells (Scrutton and Utter, 1968). Indeed, we
found that FBP1 activity in MEFs is too low to be detected. How-
ever, the expression of certain gluconeogenic enzymes including
PEP carboxykinase and FBP1 has been reported in a variety of
other type of cells originated from tissues including prostate,
stomach, lung, and small intestine (Yánez et al., 2003). For
example, human breast cancer MCF7 cells express functional
and significant amount of FBP1 (Dong et al., 2013). Moreover,
we detected both basal protein level and S63-phosphorylated
FBP1 in HCT116 cells and cells expressing shRNA-targeting
endogenous FBP1 showed increased glucose consumption
and lactate production by approximately 37% (Figures 4A and
S4B), which is consistent with the finding that genetic loss of
FBP1 often causes sudden infant death characterized by hypo-
glycemia and lactic acidosis (Emery et al., 1988). These results
confirm the existence of meaningful FBP1 in some cancer lines
to impact glucose metabolism. Meanwhile, the phosphorylation
of FBP1 may not only affect the rate of the reaction of F-1,6-P
back to F6P in glycolysis but also impinge on other functions
of FBP1 such as its modulation of the nuclear hypoxia-inducible
factor (HIF) (Li et al., 2014), although it was shown that expres-
sion levels of FBP1 play a dominant role in this process. Of
note, the activation or inhibition of FBP1 can only affect the ab-
solute values of PPP flux, which is indirectly caused by the368 Molecular Cell 62, 359–370, May 5, 2016altered glucose consumption rate but cannot affect the ratio of
PPP flux versus glycolytic flux.
Autophagy plays a critical role for cell survival in response to
nutrient deprivation and various other stresses (Galluzzi et al.,
2014; Rabinowitz and White, 2010; Xie and Klionsky, 2007).
Meanwhile, under many conditions such as amino acid and
growth factor deprivation, the utilization of glucose in the envi-
ronment could also be tightly regulated and vital for cell
fate determination. Importantly, as glucose is transported by
facilitated diffusion, which is a passive transport process, and
our ‘‘starvation medium’’ contains a regular concentration of
glucose, it is thus rational for the cells to intake glucose even in
the absence of amino acid and serum. Indeed, we found that,
although the rate of glucose consumption decreased in
response to amino acid and serum starvation in WT cells, deple-
tion of ULK1/2 led to a further significantly lower glucose con-
sumption rate (Figures 1A, 1B, and S1C–S1E). Consistently,
knockout of FIP200, an essential gene for the kinase activity of
endogenous ULK1/2 (Hara et al., 2008), reduces glucose uptake
and intracellular lactate production in mammary tumor cells (Wei
et al., 2011), pointing to a crucial role of ULK1/2 complexes in
sustaining glycolytic flux. Moreover, we found that the function
of ULK1/2 in the regulation of glucose metabolism does not
rely on downstream autophagic events (Figure 6). In addition,
ATG7, another critical factor of the autophagy core machinery,
has been reported to regulate p53-dependent cell cycle and
cell death pathways independently of autophagy during meta-
bolic stress (Lee et al., 2012). These evidences suggest that
multi-functionality could be a common feature for autophagic-
related genes.
Altogether, we have identified an adaptive mechanism for the
reprogramming of glucose metabolism in response to amino
acid and growth factor deprivation, in which ULK1/2 function
by simultaneously altering the enzymatic activities of multiple
glycolytic enzymes to sustain the production of energy and
reducing forces and thus maintain the overall metabolic homeo-
stasis besides their classical role in autophagy. An increasing
body of evidence demonstrates that disrupted cellular glucose
metabolic and redox balance tightly links with various patholog-
ical disorders (DeBerardinis and Thompson, 2012; Kawagishi
and Finkel, 2014; Levine and Puzio-Kuter, 2010; Vander Heiden
et al., 2009). Elucidation of the functions of ULK1/2 in glucose
catabolism may therefore provide new therapeutic strategies
for prevention and treatment of human metabolic diseases.
EXPERIMENTAL PROCEDURES
For detailed protocols, see Supplemental Experimental Procedures.
Cell Culture, Transient Transfection, Lentivirus Infection,
Immunoprecipitation, Western Blotting, and Animal Care
HCT116, HEK293T, and MEFs were maintained in DMEM supplemented with
10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 IU penicillin, and
100 mg/ml streptomycin at 37C in a humidified incubator containing 5%
CO2. For amino acid and serum starvation medium, unless otherwise speci-
fied, Earle’s Balanced Salts Solution (EBSS) (cat. 24010-043; GIBCO) was
supplemented with 0.25% BSA, glucose, vitamins, and minerals at the same
concentrations as in DMEM. Polyethylenimine at a final concentration of
10 mMwas used to transfect HEK293T cells. Transfected cells were harvested
at 24 hr after transfection. Lentiviruses for infection of HCT116 andMEFs were
packaged in HEK293T cells using Lipofectamine 2000 transfection. Thirty
hours after transfection, medium was collected and added to the target cells.
Cell lysis, immunoprecipitation (IP), and western blotting were carried out as
previously described (Lin et al., 2012). All animal experiments were approved
by the Institutional Animal Care and Use Committee at Xiamen University.
Statistical Analysis
For experiments with only two groups, Student’s t test was used for statistical
comparisons. ANOVA with Tukey’s post-test (one-way ANOVA for compari-
sons between groups; two-way ANOVA for comparisons of magnitude of
changes between different groups from different cell lines or treatments)
was used to compare values among different experimental groups using the
SPSS Statistics 17.0 program. p < 0.05 was considered as statistically signif-
icant (*) and p < 0.01 as highly significant (**).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article at http://dx.doi.org/10.
1016/j.molcel.2016.04.009.
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